FDA Approved: STRENSIQ — Supplemental Application (Alexion Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for STRENSIQ (asfotase alfa) from Alexion Pharmaceuticals, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• STRENSIQ (asfotase alfa)

Snippet

SUPPL AP for STRENSIQ (ASFOTASE ALFA)